Aripiprazole tablets
Dr. Reddy’s Laboratories Ltd has launched Aripiprazole tablets, USP, a therapeutic equivalent generic version of Abilify® (aripiprazole) tablets in the United States.
Approved by the U.S. Food & Drug Administration (USFDA), Dr. Reddy’s Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30.
Abilify® is a registered trademark of Otsuka Pharmaceutical Company. fii-news.com